Bisphosphonates (pamidronate)
FDA Approved
Contents
Description
Pamidronate is a bisphosphonate that inhibits bone resorption and is used to treat various bone disorders. It has been used off-label in pediatric skeletal dysplasias and early-onset osteoarthritis to improve bone density and reduce fracture risk. The medication is administered intravenously under medical supervision.
Indications & Therapeutic Use
Paget's disease, hypercalcemia of malignancy, osteogenesis imperfecta, skeletal dysplasias
Global Availability (6 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Bisphosphonates (pamidronate) — GNH India
44 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Disodium Pamidronate Medac
EU
Disodium Pamidronate Pinewood Laboratories
EU
Disodium Pamidronate Wockhardt Uk
EU
Pamidran
EU
Pamidro-Cell
EU
Pamidronaatdinatrium Hospira
EU
Pamidronat Dinatrium Pfizer
EU
Pamidronat Hikma
EU
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Bisphosphonates (pamidronate)
| Generic Name | Bisphosphonates (pamidronate) |
| Brands | 1 brand available |
| Active Ingredient | Pamidronate disodium |
| Drug Class | Paget's disease |
| Manufacturer | Novartis |
| Dosage Forms | IV infusion 30mg, 60mg, 90mg vials |
| Medical Code | M05BA03 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 10 days |
| Reg. Status | FDA Approved |
| Countries | 6 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations7 Validated Nodes